| Q51229898 | A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease |
| Q91775903 | A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome |
| Q44560782 | Acid pH increases the stability of BSC1/NKCC2 mRNA in the medullary thick ascending limb |
| Q59590280 | Acute intermittent porphyria causes hepatic mitochondrial energetic failure in a mouse model |
| Q37693360 | Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria |
| Q36296712 | Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome |
| Q57027140 | Dyserythropoiesis evaluated by RED score and hepcidin/ferritin levels predicts response to erythropoietin in lower risk myelodysplastic syndromes |
| Q44115012 | Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice. |
| Q91321350 | Erythroid-Progenitor-Targeted Gene Therapy Using Bifunctional TFR1 Ligand-Peptides in Human Erythropoietic Protoporphyria |
| Q42906357 | Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation. |
| Q46706379 | Exploring the role of galectin 3 in kidney function: a genetic approach. |
| Q92685570 | Extrahepatic hepcidin production: The intriguing outcomes of recent years |
| Q87588017 | From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria |
| Q57161823 | Functional EPO-Hepcidin axis in Recombinant human EPO independent hemodialysis patients |
| Q91123013 | GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia |
| Q90636459 | Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria) |
| Q37618819 | Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model |
| Q58578906 | Hepatocellular carcinoma in acute hepatic porphyrias: A Damocles Sword |
| Q36624644 | Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli |
| Q39161145 | Hepcidin regulates intrarenal iron handling at the distal nephron. |
| Q38818590 | Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans |
| Q41129067 | High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria |
| Q62381824 | High urinary ferritin reflects myoglobin iron evacuation in DMD patients |
| Q50529592 | Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. |
| Q38646046 | Iron is a substrate of the Plasmodium falciparum chloroquine resistance transporter PfCRT in Xenopus oocytes |
| Q47412147 | Iron metabolism and the role of the iron-regulating hormone hepcidin in health and disease. |
| Q40140993 | Iron metabolism: State of the art. |
| Q41480174 | Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency. |
| Q88093117 | Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up |
| Q41203826 | LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders. |
| Q39412094 | Management of iron overload in hemoglobinopathies. |
| Q42478276 | Mitochondrial energetic defects in muscle and brain of a Hmbs-/- mouse model of acute intermittent porphyria |
| Q47851870 | Mutation in human CLPX elevates levels of δ-aminolevulinate synthase and protoporphyrin IX to promote erythropoietic protoporphyria |
| Q52324266 | Porphyria and kidney diseases. |
| Q38542777 | Porphyrias: A 2015 update |
| Q88291969 | Predominant role of microglia in brain iron retention in Sanfilippo syndrome, a pediatric neurodegenerative disease |
| Q71949218 | Protein kinase C isoforms in rat kidney proximal tubule: acute effect of angiotensin II |
| Q84564481 | Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model |
| Q36493422 | Recent concepts concerning the renal handling of NH3/NH4+. |
| Q87937480 | Recurrent attacks of acute hepatic porphyria: major role of the chronic inflammatory response in the liver |
| Q91428293 | Regulation and tissue-specific expression of δ-aminolevulinic acid synthases in non-syndromic sideroblastic anemias and porphyrias |
| Q54072280 | Regulation by PKC isoforms of Na(+)/H(+) exchanger in luminal membrane vesicles isolated from cortical tubules. |
| Q79144158 | Regulation of ROMK (Kir 1.1) channel expression in kidney thick ascending limb by hypertonicity: role of TonEBP and MAPK pathways |
| Q91282530 | Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1 |
| Q81093664 | Renal handling of NH3/NH4+: recent concepts |
| Q88322832 | Reply |
| Q35775491 | The microbiota shifts the iron sensing of intestinal cells. |
| Q84354621 | Zeta-crystallin mediates the acid pH-induced increase of BSC1 cotransporter mRNA stability |
| Q77698003 | [Effect of angiotensin ii on Na+/H+ exchangers of the renal tubule] |
| Q74778645 | [Role of the Na(+)-K+(NH4+)-2Cl cotransporter of the medullary ascending limb in the regulation of renal acid-base equilibrium] |